Literature DB >> 28804576

Prepubertal Hypertransfusion in Thalassemia Intermedia: A Case Report of Sustained Positive Effects on Growth, Splenic Function and Endocrine Parameters.

Surekha Tony, Shahina Daar, Mathew Zachariah, Yasser Wali.   

Abstract

We report a known case of thalassemia intermedia (Hb Dhofar) who in spite of mild thalassemic facies, attained his normal genetic height, pubertal maturity and improved self-image with minimal splenomegaly through a hypertransfusion/chelation regimen that was started just before puberty and maintained for 5 years. As there are no clear guidelines in the management of patients with thalassemia intermedia, the option of hypertransfusion/chelation during the pubertal growth spurt may alleviate some of the complications associated with thalassemia intermedia.

Entities:  

Keywords:  Hypertransfusion; Prepuberty; Thalassemia Intermedia

Year:  2012        PMID: 28804576      PMCID: PMC5547735          DOI: 10.5001/omj.2012.125

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  11 in total

1.  The natural history of thalassemia intermedia.

Authors:  Caterina Borgna-Pignatti; Maria Marsella; Nicolò Zanforlin
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

Review 2.  Optimal management of β thalassaemia intermedia.

Authors:  Ali T Taher; Khaled M Musallam; Maria Domenica Cappellini; David J Weatherall
Journal:  Br J Haematol       Date:  2011-01-20       Impact factor: 6.998

Review 3.  Thalassemia intermedia: revisited.

Authors:  Ali Taher; Hussain Isma'eel; Maria D Cappellini
Journal:  Blood Cells Mol Dis       Date:  2006-06-05       Impact factor: 3.039

4.  Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran.

Authors:  Mehran Karimi; Sezaneh Haghpanah; Ali Farhadi; Majid Yavarian
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

5.  Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.

Authors:  Athanasios Aessopos; Dimitrios Farmakis; Spyros Deftereos; Maria Tsironi; Stergios Tassiopoulos; Ioannis Moyssakis; Markisia Karagiorga
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

6.  Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.

Authors:  Ali Taher; Hussain Isma'eel; Ghassan Mehio; Daniela Bignamini; Antonis Kattamis; Eliezer A Rachmilewitz; Maria Domenica Cappellini
Journal:  Thromb Haemost       Date:  2006-10       Impact factor: 5.249

7.  Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.

Authors:  M D Cappellini; L Robbiolo; B M Bottasso; R Coppola; G Fiorelli; A P Mannucci
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

8.  Haematological and clinical features of beta-thalassaemia associated with Hb Dhofar.

Authors:  Shahina Daar; David Gravell; Hussein M Hussein; Anil V Pathare; Yasser Wali; Rajagopal Krishnamoorthy
Journal:  Eur J Haematol       Date:  2008-01       Impact factor: 2.997

9.  Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia.

Authors:  Hussain Isma'eel; Abdul Hamid El Chafic; Fuad El Rassi; Adlette Inati; Susan Koussa; Rose Daher; Walid Gharzuddin; Samir Alam; Ali Taher
Journal:  Am J Cardiol       Date:  2008-05-29       Impact factor: 2.778

10.  Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

Authors:  Ali T Taher; Khaled M Musallam; Mehran Karimi; Amal El-Beshlawy; Khawla Belhoul; Shahina Daar; Mohamed-SalahEldin Saned; Abdul-Hamid El-Chafic; Maria R Fasulo; Maria D Cappellini
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

View more
  1 in total

1.  Cardio-protective effect of regular transfusion in children with non-transfusion dependent thalassemia (NTDT): A cohort study.

Authors:  Khalfan Al Senaidi; Surekha Maveda; Niranjan Joshi; Hanan Nazir; Mohamed Elshinawy; Shoaib Al Zadjali; Abdulhakim Al Rawas; Islam Elghamry; Yasser Wali; Doaa Khater
Journal:  Acta Biomed       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.